莱美药业(300006)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300006 莱美药业

已收盘 01-12 15:00:00

{"stockData":{"symbol":"300006","market":"SZ","secType":"STK","nameCN":"莱美药业","latestPrice":5.28,"timestamp":1768201410000,"preClose":5.29,"halted":0,"volume":39258642,"delay":0,"changeRate":-0.0019,"floatShares":1056000000,"shares":1056000000,"eps":-0.1017,"marketStatus":"已收盘","change":-0.01,"latestTime":"01-12 15:00:00","open":5.28,"high":5.34,"low":5.21,"amount":207000000,"amplitude":0.0246,"askPrice":5.29,"askSize":5992,"bidPrice":5.28,"bidSize":1263,"shortable":0,"etf":0,"ttmEps":-0.1017,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1768267800000},"marketStatusCode":5,"adr":0,"adjPreClose":5.29,"symbolType":"stock","openAndCloseTimeList":[[1768181400000,1768188600000],[1768194000000,1768201200000]],"highLimit":5.82,"lowLimit":4.76,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":1055911205,"isCdr":false,"pbRate":3.04,"roa":"--","roe":"--","epsLYR":-0.0832,"committee":-0.348037,"marketValue":5575000000,"turnoverRate":0.0372,"status":1,"floatMarketCap":5575000000},"requestUrl":"/m/hq/s/300006","defaultTab":"news","newsList":[{"id":"2602994245","title":"莱美药业：截至2026年1月9日股东户数为30,689","url":"https://stock-news.laohu8.com/highlight/detail?id=2602994245","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602994245?lang=zh_cn&edition=full","pubTime":"2026-01-12 15:09","pubTimestamp":1768201752,"startTime":"0","endTime":"0","summary":"证券之星消息，莱美药业(300006)01月12日在投资者关系平台上答复投资者关心的问题。投资者提问：你好董秘，请问1月10日的股东户数是多少个？莱美药业回复：尊敬的投资者，您好。截至2026年1月9日，公司股东户数为30,689。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011200014269.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0070","300006"],"gpt_icon":0},{"id":"2601812819","title":"股市必读：莱美药业(300006)股东户数2.94万户，较上期减少6.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601812819","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601812819?lang=zh_cn&edition=full","pubTime":"2026-01-07 02:00","pubTimestamp":1767722450,"startTime":"0","endTime":"0","summary":"截至2026年1月6日收盘，莱美药业报收于5.22元，下跌0.95%，换手率2.27%，成交量23.94万手，成交额1.26亿元。股本股东变化股东户数变动截至2025年12月31日，公司股东户数为2.94万户，较12月19日减少1963户，减幅6.26%。耀匀医药已投入的1400万元中，693.18万元归成都金星所有，706.82万元归耀匀医药所有且不再返还。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010700000906.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0070","300006"],"gpt_icon":0},{"id":"2601088725","title":"莱美药业（300006）披露控股子公司诉讼事项达成和解，1月5日股价上涨2.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601088725","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601088725?lang=zh_cn&edition=full","pubTime":"2026-01-05 22:38","pubTimestamp":1767623899,"startTime":"0","endTime":"0","summary":"截至2026年1月5日收盘，莱美药业报收于5.27元，较前一交易日上涨2.53%，最新总市值为55.65亿元。该股当日开盘5.14元，最高5.38元，最低5.08元，成交额达2.44亿元，换手率为4.44%。近日，莱美药业发布关于控股子公司诉讼事项达成和解的公告。公告显示，公司控股子公司成都金星健康药业有限公司与成都耀匀医药科技有限公司等就增资协议纠纷达成和解，各方已签署补充协议，解除原增资协议。案件目前处于执行阶段，相关方已达成和解。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500040428.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300006","BK0070"],"gpt_icon":0},{"id":"2600889060","title":"每周股票复盘：莱美药业（300006）制定融资及担保管理制度","url":"https://stock-news.laohu8.com/highlight/detail?id=2600889060","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600889060?lang=zh_cn&edition=full","pubTime":"2026-01-03 03:20","pubTimestamp":1767381620,"startTime":"0","endTime":"0","summary":"截至2025年12月31日收盘，莱美药业报收于5.14元，较上周的5.26元下跌2.28%。本周，莱美药业12月29日盘中最高价报5.41元。12月31日盘中最低价报5.12元。莱美药业当前最新总市值54.27亿元，在化学制药板块市值排名93/150，在两市A股市值排名3148/5181。本周关注点公司公告汇总：莱美药业审议通过制定融资管理制度及担保管理办法的议案。其中，绩效考核方案因关联董事回避，表决结果为同意6票，其余两项议案均获全票通过。会议召集程序符合相关规定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010300002156.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","300006","BK0239"],"gpt_icon":0},{"id":"2595884377","title":"莱美药业：控股子公司暂无铁死亡研究项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2595884377","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595884377?lang=zh_cn&edition=full","pubTime":"2025-12-29 16:15","pubTimestamp":1766996111,"startTime":"0","endTime":"0","summary":"证券之星消息，莱美药业(300006)12月29日在投资者关系平台上答复投资者关心的问题。投资者提问：公司如何看待人脑工程？退行性病变这一领域，铁死亡的研究越来越深入了，瀛瑞的研究未来会考虑这一块吗？莱美药业回复：尊敬的投资者，您好。公司控股子公司四川瀛瑞医药科技有限公司暂无上述研究项目。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122900017369.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0239","300006"],"gpt_icon":0},{"id":"2593955467","title":"莱美药业：截至2025年12月19日股东户数为31,359","url":"https://stock-news.laohu8.com/highlight/detail?id=2593955467","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593955467?lang=zh_cn&edition=full","pubTime":"2025-12-23 15:42","pubTimestamp":1766475733,"startTime":"0","endTime":"0","summary":"证券之星消息，莱美药业(300006)12月23日在投资者关系平台上答复投资者关心的问题。投资者提问：您好，请问截至12月20日公司的股东人数是多少？谢谢！莱美药业回复：尊敬的投资者，您好。截至2025年12月19日，公司股东户数为31,359。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122300019587.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300006","BK0070"],"gpt_icon":0},{"id":"2591774606","title":"莱美药业：截至2025年12月10日股东户数为31,490","url":"https://stock-news.laohu8.com/highlight/detail?id=2591774606","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591774606?lang=zh_cn&edition=full","pubTime":"2025-12-16 15:09","pubTimestamp":1765868956,"startTime":"0","endTime":"0","summary":"证券之星消息，莱美药业(300006)12月16日在投资者关系平台上答复投资者关心的问题。投资者提问：截止12月9日，公司最新的股东户数是多少？莱美药业回复：尊敬的投资者，您好。截至2025年12月10日，公司股东户数为31,490。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121600019572.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300006","BK0070"],"gpt_icon":0},{"id":"2590736915","title":"莱美药业：截至2025年12月10日股东户数为31,490户","url":"https://stock-news.laohu8.com/highlight/detail?id=2590736915","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590736915?lang=zh_cn&edition=full","pubTime":"2025-12-12 15:03","pubTimestamp":1765522996,"startTime":"0","endTime":"0","summary":"证券之星消息，莱美药业(300006)12月12日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止 2025 年 12 月 10 日股东人数是多少？谢谢！莱美药业回复：答：尊敬的投资者您好。截至2025 年12 月10日，公司股东户数为31,490户。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121200018124.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0239","300006"],"gpt_icon":0},{"id":"2590582793","title":"莱美药业：积极评估AI在新药研发中的应用价值","url":"https://stock-news.laohu8.com/highlight/detail?id=2590582793","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590582793?lang=zh_cn&edition=full","pubTime":"2025-12-10 20:53","pubTimestamp":1765371183,"startTime":"0","endTime":"0","summary":"证券之星消息，莱美药业(300006)12月10日在投资者关系平台上答复投资者关心的问题。投资者提问：公司在药物筛选和临床上会使用或者引进AI智能化的辅助工具吗莱美药业回复：尊敬的投资者，您好！公司持续关注人工智能领域的前沿发展，积极评估其在新药研发、数据分析、流程优化等生产经营管理场景中的应用价值。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121000038003.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","300006","BK0239"],"gpt_icon":0},{"id":"2590530416","title":"莱美药业(300006.SZ)控股子公司取得两项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2590530416","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590530416?lang=zh_cn&edition=full","pubTime":"2025-12-10 16:11","pubTimestamp":1765354272,"startTime":"0","endTime":"0","summary":"智通财经APP讯，莱美药业(300006.SZ)公告，公司控股子公司海南莱美医疗器械有限公司(简称“莱美医疗器械”)收到海南省药品监督管理局颁发的两项《医疗器械注册证》，产品名称为：医用电子内窥镜图像处理器、电子支气管镜。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1379838.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09997","BK0239","09996","BK0070","BK1222","300006","BK1100","BK1583","BK1574","159883"],"gpt_icon":0},{"id":"2588001187","title":"莱美药业(300006.SZ)控股子公司获得药物临床试验批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2588001187","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588001187?lang=zh_cn&edition=full","pubTime":"2025-12-04 16:03","pubTimestamp":1764835400,"startTime":"0","endTime":"0","summary":"智通财经APP讯，莱美药业(300006.SZ)发布公告，近日，公司控股子公司四川瀛瑞医药科技有限公司(简称“瀛瑞医药”)自主研发的创新抗癌药物“纳米炭铁混悬注射液”(简称“纳米炭铁”)获国家药品监督管理局签发《药物临床试验批准通知书》，同意纳米炭铁联合标准放疗在实体瘤患者中开展临床试验。本次获批的临床试验将进一步验证“纳米炭铁+放疗”联合方案的安全性和潜在疗效，陆续在多个临床中心启动“纳米炭铁+放疗”研究，重点关注局部治疗难度较大的实体瘤，以期在确保安全性的前提下，进一步探索联合疗法的临床价值。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1377663.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"莱美药业(300006.SZ)控股子公司获得药物临床试验批准通知书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","300006","BK0070"],"gpt_icon":0},{"id":"2588009564","title":"莱美药业：截至2025年11月28日股东户数为33,303","url":"https://stock-news.laohu8.com/highlight/detail?id=2588009564","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588009564?lang=zh_cn&edition=full","pubTime":"2025-12-04 15:36","pubTimestamp":1764833785,"startTime":"0","endTime":"0","summary":"证券之星消息，莱美药业(300006)12月04日在投资者关系平台上答复投资者关心的问题。投资者提问：截止2025年11月28日，公司最新股东户数？莱美药业回复：尊敬的投资者，您好。截至2025年11月28日，公司股东户数为33,303。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120400018515.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300006","BK0070"],"gpt_icon":0},{"id":"2586223207","title":"莱美药业（300006）披露获得药品补充申请批准通知书，11月27日股价下跌2.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586223207","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586223207?lang=zh_cn&edition=full","pubTime":"2025-11-27 22:08","pubTimestamp":1764252506,"startTime":"0","endTime":"0","summary":"截至2025年11月27日收盘，莱美药业报收于5.27元，较前一交易日下跌2.41%，最新总市值为55.65亿元。公司近日发布公告称，重庆莱美药业股份有限公司收到国家药品监督管理局核准签发的注射用氨曲南《药品补充申请批准通知书》，通过仿制药质量和疗效一致性评价，并获准变更药品质量标准、直接接触药品的包装材料和容器。有效期为12个月，上市许可持有人应在批准之日起6个月内实施变更。截至目前，国内已有12家企业通过一致性评价。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112700038220.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0239","300006"],"gpt_icon":0},{"id":"2586022891","title":"莱美药业：获得药品补充申请批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2586022891","media":"证券日报 ","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586022891?lang=zh_cn&edition=full","pubTime":"2025-11-27 20:09","pubTimestamp":1764245340,"startTime":"0","endTime":"0","summary":"郑重声明：东方财富发布此内容旨在传播更多信息，与本站立场无关，不构成投资建议。据此操作，风险自担。                                        \n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-27/doc-infywcvv9934788.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-27/doc-infywcvv9934788.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","300006","BK0070"],"gpt_icon":0},{"id":"2586024587","title":"莱美药业最新公告：注射用氨曲南通过仿制药注射剂一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2586024587","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586024587?lang=zh_cn&edition=full","pubTime":"2025-11-27 17:13","pubTimestamp":1764234784,"startTime":"0","endTime":"0","summary":"莱美药业(300006.SZ)公告称，公司收到国家药品监督管理局核准签发的注射用氨曲南（规格：0.5g）《药品补充申请批准通知书》。该药品通过仿制药注射剂一致性评价，并同意变更药品质量标准和直接接触药品的包装材料和容器。注射用氨曲南适用于治疗敏感革兰氏阴性菌引起的感染。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112700024900.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300006","BK0070"],"gpt_icon":0},{"id":"2586987428","title":"莱美药业：截至2025年11月20日股东户数为30,614","url":"https://stock-news.laohu8.com/highlight/detail?id=2586987428","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586987428?lang=zh_cn&edition=full","pubTime":"2025-11-25 16:31","pubTimestamp":1764059470,"startTime":"0","endTime":"0","summary":"证券之星消息，莱美药业(300006)11月25日在投资者关系平台上答复投资者关心的问题。投资者提问：请问11月20日的股东人数多少，谢谢莱美药业回复：尊敬的投资者，您好。截至2025年11月20日，公司股东户数为30,614。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112500021727.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0239","300006"],"gpt_icon":0},{"id":"2584360947","title":"莱美药业：公司中选药品的销售额可通过米内网等专业医药数据平台查询","url":"https://stock-news.laohu8.com/highlight/detail?id=2584360947","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584360947?lang=zh_cn&edition=full","pubTime":"2025-11-19 21:35","pubTimestamp":1763559300,"startTime":"0","endTime":"0","summary":"证券日报网讯莱美药业11月19日在互动平台回答投资者提问时表示，公司中选药品的销售额可通过米内网等专业医药数据平台查询。（文章来源：证券日报）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-19/doc-infxyazr3411298.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-19/doc-infxyazr3411298.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","159938","09939","BK1161","300006","BK0070","BK1515","BK0239"],"gpt_icon":0},{"id":"2584960329","title":"莱美药业：与奥信阳光未签署丁苯酞正式协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2584960329","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584960329?lang=zh_cn&edition=full","pubTime":"2025-11-19 08:36","pubTimestamp":1763512573,"startTime":"0","endTime":"0","summary":"证券之星消息，莱美药业11月18日在投资者关系平台上答复投资者关心的问题。公司与奥信阳光于2021年9月签署了《项目收购意向协议》，后续未签署正式协议。若后续有相关进展，公司将根据深圳证券交易所相关规则及时履行信息披露义务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111900005643.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300006","BK0239","BK0070"],"gpt_icon":0},{"id":"2584677219","title":"莱美药业：主要聚焦抗肿瘤、消化系统等领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2584677219","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584677219?lang=zh_cn&edition=full","pubTime":"2025-11-19 08:33","pubTimestamp":1763512393,"startTime":"0","endTime":"0","summary":"证券之星消息，莱美药业(300006)11月18日在投资者关系平台上答复投资者关心的问题。投资者提问：公司正在积极寻求药物的引进和相关的合作，请问公司重点关注哪些方向？莱美药业回复：尊敬的投资者您好。公司主要聚焦抗肿瘤、消化系统及其他特色专科药物等相关领域。感谢您的关注!以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111900005630.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0070","300006"],"gpt_icon":0},{"id":"2584540229","title":"股市必读：莱美药业（300006）11月18日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2584540229","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584540229?lang=zh_cn&edition=full","pubTime":"2025-11-19 01:09","pubTimestamp":1763485755,"startTime":"0","endTime":"0","summary":"截至2025年11月18日收盘，莱美药业报收于5.22元，下跌3.87%，换手率4.27%，成交量45.06万手，成交额2.38亿元。董秘最新回复投资者： 中恒集团公开征集转让莱美药业23.43%股份事项是否还在继续？公司将持续关注控股股东所持公司股份公开征集转让事宜。如有进展，公司将根据深交所相关规则及时披露进展公告。当日关注点来自交易信息汇总：11月18日主力资金净流出4728.81万元，散户资金净流入4008.5万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111900000668.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0239","300006"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1768210355269,"stockEarnings":[{"period":"1week","weight":0.0292},{"period":"1month","weight":0.0975},{"period":"3month","weight":0.2331},{"period":"6month","weight":0.3192},{"period":"1year","weight":0.5158},{"period":"ytd","weight":0.0292}],"compareEarnings":[{"period":"1week","weight":0.0382},{"period":"1month","weight":0.0564},{"period":"3month","weight":0.0573},{"period":"6month","weight":0.1739},{"period":"1year","weight":0.2831},{"period":"ytd","weight":0.0382}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"重庆莱美药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"30689人(较上一季度增加4.40%)","perCapita":"34403股","listingDate":"2009-10-30","address":"重庆市南岸区玉马路99号","registeredCapital":"105591万元","survey":"　　重庆莱美药业股份有限公司的主营业务是医药制造。公司的主要产品是抗肿瘤药、消化系统药、肠外营养药、抗感染类。公司产品获得“2021年中国产学研合作创新与促进奖”、获得“2022年福建省科学技术进步一等奖”等多项荣誉称号。","listedPrice":16.5},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"莱美药业(300006)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供莱美药业(300006)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"莱美药业,300006,莱美药业股票,莱美药业股票老虎,莱美药业股票老虎国际,莱美药业行情,莱美药业股票行情,莱美药业股价,莱美药业股市,莱美药业股票价格,莱美药业股票交易,莱美药业股票购买,莱美药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"莱美药业(300006)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供莱美药业(300006)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}